Should I Buy UTMD? UTMD 2026 Analysis

Should You Buy Utah Medical Products Inc (UTMD) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Hold

Latest Price

61.020

1 Day change

0.30%

52 Week Range

64.460

Analysis Updated At

2026/01/26

Utah Medical Products Inc (UTMD) is not a strong buy at the moment for a beginner investor with a long-term strategy. The lack of recent positive news, declining financial performance, and neutral trading sentiment suggest limited immediate upside potential. While technical indicators show some bullish trends, they are not strong enough to justify a buy given the investor's profile and the current market conditions.

Technical Analysis

The MACD is above 0 and positively contracting, indicating mild bullish momentum. RSI is neutral at 59.541, and moving averages are bullish (SMA_5 > SMA_20 > SMA_200). Key support and resistance levels suggest the stock is trading near its pivot point (60.959), with resistance at 63.165 and support at 58.753. However, no strong signals indicate a clear breakout or trend reversal.

Options Data

Positive Catalysts

Bullish moving averages and MACD above 0 indicate mild upward momentum.

Neutral/Negative Catalysts

Declining financial performance in Q3 2025, with YoY drops in revenue (-1.93%), net income (-26.16%), EPS (-19.61%), and gross margin (-1.52%). No recent news or significant trading trends from hedge funds or insiders. Stock trend analysis suggests a potential short-term decline (-2.23% in the next week).

Financial Performance

In Q3 2025, revenue dropped to $9.81M (-1.93% YoY), net income dropped to $2.63M (-26.16% YoY), EPS dropped to $0.82 (-19.61% YoY), and gross margin dropped to 57.11% (-1.52% YoY). These metrics indicate a decline in profitability and operational efficiency.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No data on analyst ratings or price target changes available.

Analyst Rating

Wall Street analysts forecast UTMD stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for UTMD is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

Buy

Hold

Sell

Current: 60.840

Low

Averages

High